HomeInsightsStock Comparison

Bafna Pharmaceuticals Ltd vs Emcure Pharmaceuticals Ltd Stock Comparison

Bafna Pharmaceuticals Ltd vs Emcure Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Bafna Pharmaceuticals Ltd is ₹ 89.64 as of 16 Jul 15:30.
  • The P/E Ratio of Bafna Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Emcure Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Bafna Pharmaceuticals Ltd changed from ₹ 2.1 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Emcure Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Bafna Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Emcure Pharmaceuticals Ltd for the Mar '25 is ₹ 2120 crore as compare to the Dec '24 revenue of ₹ 1959 crore. This represent the growth of 8.23%.
  • The ebitda of Bafna Pharmaceuticals Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Emcure Pharmaceuticals Ltd for the Mar '25 is ₹ 396.48 crore as compare to the Dec '24 ebitda of ₹ 358.5 crore. This represent the growth of 10.59%.
  • The net profit of Bafna Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Emcure Pharmaceuticals Ltd changed from ₹ 140.97 crore to ₹ 197.24 crore over 8 quarters. This represents a CAGR of 18.29% .
  • The Dividend Payout of Bafna Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Emcure Pharmaceuticals Ltd changed from 25.8 % on March 2020 to 22.53 % on March 2024 . This represents a CAGR of -2.67% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Bafna Pharmaceuticals Ltd

  • Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
  • The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
  • Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
  • During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

About Emcure Pharmaceuticals Ltd

  • Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
  • Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
  • They are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled to reach target markets across over 70 countries, with a strong presence in India, Europe and Canada.

Bafna Pharmaceuticals Ltd News Hub

News

Bafna Pharmaceuticals to table results

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 M...

Read more

21 May 2025 10:24

News

Bafna Pharmaceuticals announces board meeting date

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 Fe...

Read more

28 Jan 2025 17:34

News

Bafna Pharmaceuticals to discuss results

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 N...

Read more

04 Nov 2024 18:39

News

Bafna Pharmaceuticals schedules AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

05 Sep 2024 10:29

News

Bafna Pharmaceuticals to convene AGM

Bafna Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

04 Sep 2024 17:49

News

Bafna Pharmaceuticals to declare Quarterly Result

Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 A...

Read more

10 Aug 2024 13:56

Emcure Pharmaceuticals Ltd News Hub

News

Emcure Pharmaceuticals signs exclusive agreement with Sanofi India

Emcure Pharmaceuticals (Emcure) and Sanofi India (SIL) today entered into an exclusive dis...

Read more

16 Jul 2025 17:38

News

Emcure Pharmaceuticals appoints President ' India Business

Emcure Pharmaceuticals has appointed R.S. Vasan as President ' India Business and Senior M...

Read more

14 Jul 2025 13:17

News

Emcure Pharma gains after Sanand facility gets zero observations from USFDA

The inspection conducted from 30 June 2025 to 08 July 2025 and concluded without issuance ...

Read more

10 Jul 2025 09:50

News

Board of Emcure Pharmaceuticals recommends final dividend

Emcure Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

22 May 2025 18:02

News

Emcure Pharmaceuticals to announce Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 ...

Read more

14 May 2025 15:15

News

Emcure Pharma's pune facility receives VAI status from USFDA

The company received the Establishment Inspection Report (EIR) from the USFDA following an...

Read more

21 Apr 2025 11:09

SWOT Analysis Of Bafna Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bafna Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Emcure Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Bafna Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd

Which company has a larger market capitalization, Bafna Pharmaceuticals Ltd or Emcure Pharmaceuticals Ltd?

Market cap of Bafna Pharmaceuticals Ltd is 212 Cr while Market cap of Emcure Pharmaceuticals Ltd is 25,846 Cr

What are the key factors driving the stock performance of Bafna Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd?

The stock performance of Bafna Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bafna Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd?

As of July 16, 2025, the Bafna Pharmaceuticals Ltd stock price is INR ₹89.64. On the other hand, Emcure Pharmaceuticals Ltd stock price is INR ₹1363.85.

How do dividend payouts of Bafna Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd compare?

To compare the dividend payouts of Bafna Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions